Coherus Biosciences | CHRS - Umlaufvermögen





Umlaufvermögen Veränderung Datum
AbbVie USD 33.53B 4.47B 2026-03
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Akebia Therapeutics USD 243.48M 9.47M 2026-03
ALKERMES USD 1.52B 164.26M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
Amgen USD 31.48B 2.42B 2026-03
Baxter International USD 6.99B 142M 2026-06
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Fujifilm JPY 1.72T 2.2B 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Merck USD 35.02B 8.5B 2026-03
Myriad Genetics USD 289M 23.8M 2026-06
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xencor USD 482.85M 116.97M 2026-03
Zoetis USD 6.47B 294M 2026-03